The Global Oral Cavity Cancer market is expected to grow during the forecast period 2019-2026 with the growing awareness towards oral diseases and increasing healthcare expenditures

Hyderabad, June 21, 2019 -- The "Oral Cavity Cancer Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2026" report has been added to Datamintelligence.com's offering.

Click here to get your copy of free sample https://www.datamintelligence.com/research-report/oral-cavity-cancer-market

Oral Cavity Cancer Market Trends : Drivers and Restraints
⦁The Oral Cavity Cancer market growth is driven by several factors such as rising prevalence of oral cancer, growing awareness towards oral diseases and increasing healthcare expenditures.
⦁According to The American Cancer Society Society’s estimations, the number of oral cavities and oropharyngeal cancers cases in the US will reach about 51,540 cases in 2018, and an estimated 10,030 people will die of these cancers.
⦁The market is hindered by several factors such as the high cost of treatment and risks of recurrence of cancer even after the procedure and related side effects. In 2015, according to the Dharamshila Hospital, India, the cost of the treatment of the oral cancers can range from USD 2,995 to USD 14,979.
⦁According to the Oral Cancer Foundation, there were 49,750 cases diagnosed among Americans in 2017 with the oral oropharyngeal cancer. It is estimated that 9,750 deaths will be accounted for the same, killing one patient every 24 hours.
⦁Moreover, according to the Centres for Disease Control and Prevention, in 2015, the total U.S. healthcare expenditure accounted for 17.8% of the overall gross domestic product (GDP), which accounted for USD 3.2 trillion.

Oral Cavity Cancer Market Segmentation:
By Type
⦁Verrucous Carcinoma
⦁Squamous Cell Carcinoma
⦁Lymphomas
⦁Minor Salivary Gland Carcinomas
⦁Others
By Region
⦁Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
⦁Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
⦁North America (The USA, Canada, Mexico)
⦁South America (Brazil, Argentina, Rest of South America)
⦁Rest of the World

Key Points covered in the report
⦁Oral Cavity Cancer Market – Methodology and Scope
⦁Oral Cavity Cancer Market – Trends
⦁Oral Cavity Cancer Market – Industry Analysis
⦁Geographical Analysis
⦁Competitive Landscape
⦁Company Profiles

Oral Cavity Cancer Market Key Companies
Bristol-Myers Squibb Company, Qilu Pharmaceutical Co., Teva Pharmaceutical Industries, Eli Lilly and Company, F. Hoffmann-La Roche, Merck & Co., Inc., Novartis AG, and Pfizer Inc.

For more information about this report visit https://www.datamintelligence.com/research-report/oral-cavity-cancer-market

DataM Intelligence also offers Custom Research services providing focused, comprehensive and tailored research.

1st floor, Phoenix Tech Tower, Plo no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana.

DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence.

This release was published on openPR.